Key result
DVT prophylaxis requires balancing complication risks against thromboembolism prevention.
Answers are grounded in this paper and cite their sources.
Literature review evaluates prophylactic strategies against venous thromboembolism across clinical procedures, highlighting the need to balance bleeding risks with clot prevention.
The prophylaxis of deep venous thrombosis is critically related to potentially life-threatening pulmonary embolism. Each of the available agents has benefits and drawbacks which are reviewed in this article. While the search for the ideal method of prophylaxis continues, the appropriate agent appears to be one that balances the risk of complication with the potential risk of development of thromboembolism. Recommendations for acceptable prophylaxis are made for various procedures.
No takes yet. Share an insight, caveat, or question.
Edward W Gold (1988) conducted a review in Deep venous thromboembolism and pulmonary embolism. Deep venous thrombosis prophylaxis agents was evaluated on Prevention of deep venous thromboembolism and pulmonary embolism. Prophylactic agents for deep venous thrombosis must balance complication risks against thromboembolism risk, though no quantitative results are reported in the abstract.
Synapse has enriched 10 related papers. Consider them for comparative context: